Monday, August 31, 2020

Ionis Pharmaceuticals Acquires Rest Of Akcea Therapeutics In $500M Deal

Carlsbad-based Ionis Pharmaceuticals said this morning that it is acquiring the remaining stake that it does not already own of Akcea Therapetuics. According to Ionis Pharmaceuticals, it will pay $18.15 per share in cash for the remaining 24% of shares of Akcea common stock it does not already own. The deal is worth approximately $500M. Ionis

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.